IP Library Granted Patent US 7,312,368
Granted Patent B2
US 7,312,368 · App. 10/581,418 · Granted Dec 25, 2007

Method for selective reduction of aromatic compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,312,368
App. No.
10/581,418
Granted
Dec 25, 2007
Kind
B2
Abstract

A method for the selective reduction of an aromatic compound. The present invention provides a method for pre-venting the reduction of at least one halogen substituted aromatic ring of an aromatic compound, while allowing the reduction of at least one functional group on the aromatic compound. In the present invention at least one hydroxyl group is placed on the at least one halogen substituted aromatic ring to be protected from reduction. The aromatic compound is then reacted with at least one alkali metal in at least one nitrogen containing base and at least one alcohol at a ratio of the alcohol to the nitrogen containing base at which the aromatic ring with the hydroxyl group is protected from reduction, while the desired functional group is reduced.

Claims (26)

1. A method for preventing the dehalogenation of an aromatic compound, the method comprising:

protecting an at least one halogen substituted aromatic ring of the aromatic compound with at least one hydroxyl group located on the at least one halogen substituted aromatic ring of the aromatic compound;

reacting the aromatic compound with at least one alkali metal or alkaline earth metal in an at least one nitrogen containing base and at least one alcohol; and

maintaining a ratio of the alcohol to the nitrogen containing base at which the at least one halogen substituted aromatic ring is not dehalogenated.

2. The method of claim 1 wherein the at least one alkali metal or alkaline earth metal includes an alkali metal or alkaline earth metal selected from the group consisting of Li, Na, K, Ca and mixtures thereof.

3. The method of claim 1 wherein the at least one nitrogen containing base includes a base selected from the group of ammonia, methylamine, ethylamine and mixtures thereof.

4. The method of claim 1 wherein the ratio of the alcohol to the nitrogen containing base is about 1:1 to about 1:4.

5. The method of claim 1 further including removing the at least one hydroxyl group from the at least one aromatic ring.

6. A method for the selective reduction of a compound having at least one first aromatic ring including at least one halogen group and at least one second aromatic ring, the method comprising:

protecting the at least one first halogen substituted aromatic ring with at least one hydroxyl group located on the at least one first halogen substituted aromatic ring;

reducing an at least one functional group on the at least one second aromatic ring by reacting the compound with at least one alkali metal or alkaline earth metal in the presence of at least one nitrogen containing base and at least one alcohol; and

maintaining a ratio of the nitrogen containing base to the alcohol, at which the at least one first halogen substituted aromatic ring is not reduced.

7. The method of claim 6 wherein the at least one alkali metal or alkaline earth metal includes an alkali metal or alkaline earth metal selected from the group consisting of Li, Na, K, Ca and mixtures thereof.

8. The method of claim 6 wherein the at least one nitrogen containing base includes a base selected from the group of ammonia, methylamine, ethylamine and mixtures thereof.

9. The method of claim 6 wherein the ratio of the alcohol to the nitrogen containing base is about 1:1 to about 1:4.

10. The method of claim 6 further including removing the at least one hydroxyl group from the at least one aromatic ring after the selective reduction.

11. The method of claim 6 wherein the at least one second aromatic ring is reduced to a 1,3-cyclohexadiene or 1,4-cyclohexadiene.

12. The method of claim 6 wherein the at least one second aromatic ring includes at least one halogen group wherein the at least one second aromatic ring is dehalogenated.

13. A method for selective dehalogenation of an aromatic compound having at least one first aromatic ring including at least one halogen group and at least one second aromatic ring having at least one halogen group, the method comprising:

protecting the at least one first aromatic ring with at least one hydroxyl group located on the at least one first aromatic ring;

dehalogenating the at least one second aromatic ring by reacting the aromatic compound with at least one alkali metal or alkaline earth metal in the presence of at least one nitrogen containing base and at least one alcohol; and

maintaining a ratio of the alcohol to the nitrogen containing base at which the at least one halogen group on the at least one first aromatic ring is retained on the first aromatic ring.

14. The method of claim 13 wherein the at least one alkali metal or alkaline earth metal includes an alkali metal or alkaline earth metal selected from the group consisting of Li, Na, K, Ca and mixtures thereof.

15. The method of claim 13 wherein the at least one nitrogen containing base includes a base selected from the group of ammonia, methylamine, ethylamine and mixtures thereof.

16. The method of claim 13 wherein the ratio of the alcohol to the nitrogen containing base is about 1:1 to about 1:4.

17. The method of claim 13 further including removing the at least one hydroxyl group from the at least one aromatic ring after the selective dehalogenation.

Assignments (4)
RELEASE OF PATENT SECURITY INTERESTS RECORDED AT REEL 032480, FRAME 0001 Recorded Nov 16, 2023
From: DEUTSCHE BANK AG NEW YORK BRANCH, AS COLLATERAL AGENT
To: THERAKOS, INC.; MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS LLC (F/K/A MALLINCKRODT US HOLDINGS INC.); MALLINCKRODT CARRIBEAN, INC.; MALLINCKRODT US POOL LLC; MNK 2011 LLC (F/K/A MALLINCKRODT INC.); LUDLOW LLC (F/K/A LUDLOW CORPORATION); CNS THERAPEUTICS, INC.; MALLINCKRODT ENTERPRISES HOLDINGS LLC (F/K/A MALLINCKRODT ENTERPRISES HOLDINGS, INC.); MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS LLC (F/K/A MALLINCKRODT BRAND PHARMACEUTICALS, INC.); MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC.; MALLINCKRODT HOSPITAL PRODUCTS IP UNLIMITED COMPANY (F/K/A MALLINCKRODT HOSPITAL PRODUCTS IP LIMITED); MALLINCKRODT ARD IP UNLIMITED COMPANY (F/K/A MALLINCKRODT ARD IP LIMITED); OCERA THERAPEUTICS LLC (F/K/A OCERA THERAPEUTICS, INC.); SPECGX LLC; STRATATECH CORPORATION; SUCAMPO PHARMA AMERICAS LLC; VTESSE LLC (F/K/A VTESSE INC.); MALLINCKRODT PHARMACEUTICALS IRELAND LIMITED; MALLINCKRODT PHARMA IP TRADING UNLIMITED COMPANY (F/K/A MALLINCKRODT PHARMA IP TRADING D.A.C.); INFACARE PHARMACEUTICAL CORPORATION; ST SHARED SERVICES LLC; IKARIA THERAPEUTICS LLC; INO THERAPEUTICS LLC
Reel/Frame 065609/0322 →
SECURITY INTEREST Recorded Mar 19, 2014
From: MALLINCKRODT INTERNATIONAL FINANCE S.A.; MALLINCKRODT CB LLC; MALLINCKRODT FINANCE GMBH; MALLINCKRODT US HOLDINGS INC.; MALLINCKRODT CARIBBEAN, INC.; MALLINCKRODT US POOL LLC; MALLINCKRODT INC.; LUDLOW CORPORATION; CNS THERAPEUTICS, INC.; ENTERPRISES HOLDINGS, INC.; MALLINCKRODT ENTERPRISES LLC; MALLINCKRODT LLC; LAFAYETTE PHARMACEUTICALS LLC; LIEBEL-FLARSHEIM COMPANY LLC; MALLINCKRODT BRAND PHARMACEUTICALS, INC; MALLINCKRODT VETERINARY, INC.; MALLINCKRODT US HOLDINGS LLC; IMC EXPLORATION COMPANY; MEH, INC; MALLINCKRODT ENTERPRISES HOLDINGS, INC.
To: DEUTSCHE BANK AG NEW YORK BRANCH
Reel/Frame 032480/0001 →
CHANGE OF LEGAL ENTITY Recorded Aug 16, 2011
From: MALLINCKRODT INC.
To: MALLINCKRODT LLC
Reel/Frame 026754/0001 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 21, 2006
From: WANG, PETER XIANQI; MOSER, FRANK W.
To: MALLINCKRODT INC.
Reel/Frame 017822/0397 →